Notizie
durante la sospensione della didattica gli studenti del II anno II semestre TLB potranno accedere tramite il seguentre link ad audiolezioni e materiale didattico : vef32wt
durante la sopsensione della didattica gli studenti del IV anno II semestre del corso di LM in Medicina e Chirurgia potranno accedere tramite il seguente link ad audiolezioni e materiale didattico relativo agli argomenti di patologia della cute e patologia del sistema endocrino: eupmcmw
Orari di ricevimento
martedì-veberdi 9.00-12.00
Curriculum
http://www.dmcm.uniroma1.it/sites/dip-dmcm/files/Pilozzi.pdf#overlay-con...
FORMATO EUROPEO PER IL CURRICULUM VITAE
INFORMAZIONI PERSONALI
Nome PILOZZI EMANUELA
Indirizzo 12 VIA ANTONIO VIVALDI , 00199 ROMA
Telefono 06 86391451
Fax
E-mail emanuela.pilozzi@uniroma1.it
Nazionalità ITALIANA
Data di nascita 17/05/1968, Roma
ESPERIENZA LAVORATIVA
da 1999 a oggi
07/01/2014 - ricercatore settore scientifico-disciplinare MED08 (anatomia patologica) Università “La Sapienza” Roma.
- da 2001: strutturazione ospedaliera come dirigente di i livello nella UOC di Anatomia Patologica (responsabile Prof Luigi Ruco) presso Azienda Ospedaliera Sant’Andrea, via di Grottarossa 1035, 00189 Roma
- idoneita’ abilitazione scientifica seconda fascia settore concorsuale 06A4 (Anatomia Patologica), Bando 2012
• Nome e indirizzo del datore di lavoro Universita’ di Roma “LA SAPIENZA” Ple Aldo Moro 5
ISTRUZIONE E FORMAZIONE
1993
1997 • Conseguimento della laurea in Medicina e Chirurgia presso Università di Roma “La Sapienza” con votazione 110/110 cum laude.
• Conseguimento del titolo di Specialista in Anatomia Patologica, presso Università di Roma “La Sapienza” con votazione 70/70 cum laude.
ESPERIENZA LAVORATIVA
ALL’ESTERO
1996-1998
Agosto –Settembre 2007 • Research fellow presso il laboratorio di Ematologia Molecolare del “Department of Cellular Science” dell’Università di Oxford, Regno Unito, sotto la guida dei Professori Kevin Gatter e James Wainscoat.
• Visiting Doctor Departement of Pathology, sotto la supervisione del Prof. Stephan Hubscher, University of Birmingham, UK
PRINCIPALI AMBITI DI INTERESSE DIAGNOSTICO
• Malattie dell’apparato digerente.
• Biologia molecolare applicata ai tessuti
Allegato n.1
PUBBLICAZIONI IN EXTENSO della Dott.ssa Emanuela Pilozzi
1. M-Padura I, De Castellarnau C, Uccini S, Pilozzi E, Natali PG, Nicotra MR, Ughi F, Azzolini C, Dejana E, Ruco LP: Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 1995, 175:51-7 (IF= 5.759)
2. Ruco LP, Uccini S, Stoppacciaro A, Pilozzi E, Morrone S, Gallo A, De Vincentis M, Santoni A, Baroni CD: The lymphoepithelial organization of the tonsil: an immunohistochemical study in chronic recurrent tonsillitis. J Pathol 1995, 176:391-8. (IF= 5.759)
3. Uccini S, Pilozzi E, Stoppacciaro A, Sirianni MC, Vicenzi L, Angeloni A, Santarelli R, Faggioni A, Cerimele D, Masala MV, Cottoni F, Baroni CD, Ruco LP: Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 is not detectable in peripheral blood mononuclear cells of the relatives of sporadic KS patients. J Invest Dermatol 1997, 108(1):119-20 (IF= 4.535)
4. Pilozzi E, Stoppacciaro A, Rendina E, Ruco LP: Monocyte chemotactic protein-1 in the inflammatory pseudotumour of the lung. Mol Pathol 1998, 51(1):50-2. (IF= 2.245)
5. Ruco LP, Pilozzi E, Martine Wedard B, Marzullo A, D’Andrea V, De Antoni E, Silvestrini G, Bonetti F: Epithelioid lymphangioleiomyomatosis-like tumour of the uterus in a patient without tuberous sclerosis: a lesion mimicking epithelioid leiomyosarcoma. Histopathology 1998, 33(1):91-3. (IF= 3.216)
6. Pilozzi E, Fidler C, Boultwood J, Wainscoat JS: BRCA2 gene deletion is rare in chronic lymphocytic leukemia. Am J Hematol 1998, 59(4):318. (IF= 1.882)
7. Pilozzi E, Pulford K, Jones M, Müller-Hermelink HK, Falini B, Ralfkier E, Pileri S, Pezzella F, De Wolf-Peeters C, Arber D, Stein H, Mason D, Gatter K: Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol 1998, 186(2):140-3. (IF= 5.759)
8. Pilozzi E, Müller-Hermelink HK, Falini B, De Woolf-Peeters C, Fidler C, Gatter K, Wainscoat J: Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol 1999, 188(3):267-70. (IF= 5.759)
9. Pilozzi E, Talerico C, Platt A, Fidler C, Ruco LP: p73 gene mutations in gastric adenocarcinomas. Mol Pathol 2003 Feb;56(1):60-2. (IF= 2.245)
10. Pilozzi E, Talerico C, Uccini S, Addesso M, Rossi R, Vago L, Antinori A, Ruco LP: B cell clonality in multiple localizations of primary central nervous system lymphomas in AIDS patients. Leuk Lymphoma 2003, 44(6):963-6. (IF= 1.559)
11. Ruco LP, Di Napoli A, Pilozzi E, Talerico C, Uccella I, Giancola ML, Alba L, Antinori A: Peripheral T cell lymphoma with cytotoxic phenotype: an emerging disease in HIV-infected patients. AIDS Res Hum Retroviruses 2004, 20(2):129-33. (IF= 2.513)
12. Scarpino S, Di Napoli A, Rapazzotti Onelli M, Pilozzi E, Ruco L: Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression. Br J Cancer 2004, 16;91(4):703-6. (IF= 4.459)
13. Lahner E, Vaira D, Figura N, Pilozzi E, Pasquali A, Severi C, Perna F, Delle Fave G, Annibale B: Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2004; 9(5):436-42. (IF= 2.477)
14. Pilozzi E, Rapazzotti Onelli M, Ziparo V, Mercantini P, Ruco L: CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation. J Pathol 2004, 204(3):289-95. (IF= 5.759)
15. Larussa D, Grisetti S, Pilozzi E, Concorsi P, Pisa R, Ruco L, Antinori A: Acute megakaryoblastic leucemia in a patient receiving HAART. Am J Hematol 2005, 80: 89-90 (IF= 1,882)
16. Corleto VD, Zykaj E, Mercantini P, Pilozzi E, Rossi M, Carniccio A, Di Giulio E, Riparo V, Delle Fave G: Is colonoscopy suffi cient for colorectal cancer surveillance in all HNPCC patients? World J Gastroenterol 2005, 11 47: 7541-44.
17. Eramo A, Ricci-Vitiani L, Pallini R, Zeuner A, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R: Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13(7):1238-41 (IF= 7.463)
18. Ramacciato G, Nigri GR, Aurello P, D’Angelo F, Pezzoli F, Rossi S, Pilozzi E, Ercolani G, Ravaioli M: Giant hepatic adenoma with bone marrow metaplasia not associate with oral contraceptive intake. W J Surg Oncol 2006, 4: 58
19. Ramacciato G, Nigri G, D'Angelo F, Aurello P, Bellagamba R, Colarossi C, Pilozzi E, Del Gaudio M: Emergency laparotomy for misdiagnosed biliary cystadenoma originating from caudate lobe. World J Surg Oncol. 2006 Nov 7;4:76.
20. Ricci-Vitiani L, Lombardi D, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification, isolation and expansion of human colon cancer initiating cells. Nature, 2007, 445:111-115 (IF: 26.681)
21. Scarpino S, Di Napoli A, Stoppacciaro A, Antonelli M, Pilozzi E, Chiarle R, Palestro G, Marino M, Facciolo F, Rendina EA, Webster KE, Kinkel SA, Scott HS, Ruco L. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol. 2007,149:504-12. (IF= 2.747)
22. Cavallini M, Cavaniglia D, Felicioni F, Vitale V, Pilozzi E, Ziparo V. Large periampullary villous tumor of the duodenum. J Hepatobiliary Pancreat Surg. 2007;14:526-8. (IF= 1.182)
23. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15:504-14. (IF= 7.463)
24. Luong TV, Pilozzi E, Bearzi I, Bordi C. Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms. Virchows Arch, 2008, 452:169-74. (IF= 2.251)
25. Petrocca F, Visione R, Onelli RM, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cvazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, secchione A. E2F1- regulated microRNAs impari TGFbeta-dependent cell cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13: 272-286 (IF=24).
26. Melotti F, Mari E, Giorgiana F, Fidanza L, Carlesimo M, Pilozzi E, Raffa E, Camplone G, Bartolazzi A. Actinic Reticulosis with clonal TCR (T-cell receptor) gene rearrangement. Eur J Dermatol 2008, 18: 598-600. (IF: 1,175)
27. Scarpino S, Duranti E, Stoppacciaro A, Pilozzi E, Natoli G, Sciacchitano S, Luciani E, Ruco L. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness. J Pathol 2009, 218: 487.(IF: 5,121)
28. Pilozzi E, Del Prete F, De Dominicis C, Angelo Rendina E, P Ruco L. True thymic hyperplasia associated with thymic hemorrhage in an adult patient. Pathol Res Pract 2009.(IF: 1,029)
29. Muroni M, D'Angelo F, Pezzatini M, Sebastiani S, Noto S, Pilozzi E, Ramacciato G. Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):97-9.(IF: 1,183)
30. Baiocchi M, Biffoni M, Ricci-Vitiani L, Pilozzi E, De Maria R. New models for cancer research: human cancer stem cell xenografts. Curr Opin Pharmacol. 2010 Aug;10(4):380-384. (IF:7,259)
31. Ricci-Vitiani L, Mollinari C, di Martino S, Biffoni M, Pilozzi E, Pagliuca A,Chiara de Stefano M, Circo R, Merlo D, De Maria R, Garaci E. Thymosin {beta}4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J. 2010 24(11): 4291-301. (IF: 6,4)
32. Lorenzon L, Ferri M, Pilozzi E, Torrisi MR, Ziparo V, French D. Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature. Int J Colorectal Dis. 2011, 26:135-142.(IF: 2.10)
33. Vannella L, Lahner E, Bordi C, Pilozzi E, Di Giulio E, Corleto VD, Osborn J, Delle Fave G, Annibale B. Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Dig Liver Dis. 2011 43:295-299 (IF:2.97)
34. La Torre M, Ferrari L, Cosenza G, Nava AK, Mercantini P, Pasanen A, Pilozzi E, Ziparo V. Esophageal small cell carcinoma. Am Surg 2010 76: 28-30. (IF: 1,154)
35. Pilozzi E, Ferri M, Rapazzotti Onelli M, Mercantini P, Corigliano N, Duranti E, Dionisi L, Felicioni F, Virgilio E, Ziparo V, Ruco L. Prognostic significance of 18q LOH in sporadic colorectal carcinoma. Am Surg 2011 77: 38-43. (IF: 1,154)
36. Caterino S, Lorenzon L, Petrucciani N, Iannicelli E, Pilozzi E, Romiti A, Cavallini M, Ziparo V. Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World J Surg Oncol 2011, 9:13 (IF:1,1)
37. Pagnini C, Corleto VD, Mangoni ML, Pilozzi E, Torre MS, Marchese R, Carnuccio A, Giulio ED, Fave GD. Alteration of Local Microflora and α-defensins Hyper-production in Colonic Adenoma Mucosa. J Clin Gastroenterol. 2011 Feb 22. [Epub ahead of print] (IF: 2,207)
38. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, Di Mario F Gastritis: the histology report. Dig Liver Dis. 2011 Mar;43 Suppl 4:S373-84. (IF: 2,97)
39. L Vannella, A Sbrozzi-Vanni, E Lahner, C Bordi, E Pilozzi, V D Corleto , G Delle Fave, B Annibale. Development of Type I Gastric Carcinoid in patients with Chronic atrophic gastritis. Alimentary Pharmacology & Therapeutics 2011, 33(12): 1361-69. (IF: 4.3)
40. Di Florio A, Adesso L, Pedrotti S, Capurso G, Pilozzi E, Corbo V, Scarpa A, Geremia R, Delle Fave G, Sette C. Src kinase activity coordinates cell adhesion and spreading with activation of mTOR in pancreatic endocrine tumor cells. Endocr Relat Cancer. 2011 Jun 28. 18(5):541-54 (IF:4.36)
41. Merola E, Sbrozzi-Vanni A, Panzuto F, D'Ambra G, Di Giulio E, Pilozzi E, Capurso G, Lahner E, Bordi C, Annibale B, Delle Fave G. Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate. Neuroendocrinology. 2012, 95:207-13. (IF:2,37)
42. Pilozzi E, Cacchi C, Di Napoli A, Pini B, Duranti E, D'Andrilli A, Ruco L. Primary malignant tumour of the lung with neuroendocrine and melanoma differentiation. Virchows Arch. 2011 ;459(2):239-43. (IF: 2,49)
43. Iannicelli E, Sapori A, Panzuto F, Pilozzi E, Delle Fave G, David V. Oesophageal GIST: MDCT Findings of Two Cases and Review of the Literature. J Gastrointest Cancer. 2012, 43: 481-85.
44. Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E, Duranti E, Martinelli S, Rinaldo C, Zeuner A, Maugeri-Saccà M, Eramo A, De Maria R. Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death Differ. 2012, 19:768-778. (IF: 8,84)
45. La Torre M, Lorenzon L, Pilozzi E, Barucca V, Cavallini M, Ziparo V, Ferri M. Number of harvested lymph nodes is the main prognostic factor in Stage IIa colorectal cancer patients. J Surg Oncol. 2012, 106: 469-474. (IF: 2,1)
46. Lorenzon L, Pilozzi E, La Torre M, Ziparo V, Ferri M. Impact and prognostic implications of colon cancers stage II sub-classification through the years. Int J Colorectal Dis. 2012, 27: 1311-8. (IF: 2,38)
47. Virgilio E, Pucci E, Pilozzi E, Mongelli S, Cavallini M, Ferri M. Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery giving multiple hepatic deposits and associated with colon cancer. Am Surg. 2012 May;78(5):262-4 (IF: 1,154)
48. Lorenzon L, Ziparo V, Cavaniglia D, Pilozzi E, Iannicelli E, Caterino S. Clinical-pathological features of gastrointestinal stromal tumors presenting associated with other neoplasms: a brief report. Minerva Chir. 2012 Apr;67(2):175-80.
49. Aurello P, Petrucciani N, D'Angelo F, Pilozzi E, Pulcini F, Cicchini C, Nigri GR, Ramacciato G. Squamous cell carcinoma of the pancreas presenting with upper gastrointestinal bleeding. Am Surg. 2012 May;78(5):284-5. (IF: 1,154)
50. Adesso L, Calabretta S, Barbagallo F, Capurso G, Pilozzi E, Geremia R, Delle Fave G, Sette C. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Oncogene. 2013, 32:2848-57 (IF:6,37)
51. Corleto VD, Pagnini C, Cattaruzza MS, Zykaj E, Di Giulio E, Margagnoni G, Pilozzi E, D'Ambra G, Lamazza A, Fiori E, Ferri M, Masoni L, Ziparo V, Annibale B, Delle Fave G. Is proliferative colonic disease presentation changing? World J Gastroenterol. 2012 Dec 7;18(45):6614-9. (IF:2.54)
52. Lorenzon L, Castaldo P, Bartolazzi A, Rossi Del Monte S, Camboni A, Pilozzi E, Salvi PF, Ziparo V. Debating the presentation, morphology, origin, and prognosis of a combined hepatocellular-cholangiocarcinoma. Dig Dis Sci. 2013 Aug;58(8):2423-4. (IF:2.26)
53. Ferri M, Lorenzon L, Onelli MR, La Torre M, Mercantini P, Virgilio E, Balducci G, Ruco L, Ziparo V, Pilozzi E. Lymph node ratio is a stronger prognotic factor than microsatellite instability in colorectal cancer patients: Results from a 7 years follow-up study. Int J Surg. 2013;11(9):1016-21. (IF:1,436)
54. Vinciguerra GL, Mercantini P, La Torre M, Pilozzi E, Ziparo V, Vecchione A. Transitional Cell Carcinoma of the Retrorectal Space Arisen in Tailgut Cyst: A Case Report and Review of the Literature. Int J Surg Pathol. 2013, 22:280-85.(IF: 0.76)
55. Di Napoli A, Al-Jadiri MF, Talerico C, Duranti E, Pilozzi E, Trivedi P, Anastasiadou E, Alsaadawi AR, Al-Darraji AF, Al-Hadad SA, Testi AM, Uccini S, Ruco L. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells. Pediatr Blood Cancer. 2013 Dec;60(12):2068-72. (IF: 2.35)
56. Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, Biffoni M, Pagliuca A, Martinetti D, Memeo L, Milella M, De Maria R, Eramo A. Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts. J Exp Clin Cancer Res. 2013 Nov 16;32(1):91 (IF:3)
57. Lahner E, Pilozzi E, Esposito G, Galli G, Annibale B. Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge. Scand J Gastroenterol 2014, 49:1447-55 (IF: 2.1)
58. Lorenzon L, Mercantini P, Ferri M, La Torre M, Sparagna A, Balducci G, Tarantino G, Romiti A, Pilozzi E, Ziparo V. Profiling the prognosis of gastric cancer patients: is it worth correlating the survival with the clinical/pathological and molecular features of gastric cancers? Scientific World Journal. 2013 Dec 24;2013:196541.(IF:1.7)
59. Iannicelli E, Di Renzo S, Ferri M, Pilozzi E, Di Girolamo M, Sapori A, Ziparo V, David V. Accuracy of high-resolution MRI with lumen distention in rectal cancer staging and circumferential margin involvement prediction. Korean J Radiol 2014, 15:37-44 (IF:1.5)
60. Panzuto F, Merola E, Rinzivillo M, Partelli S, Campana D, Iannicelli E, Pilozzi E, Mercantini P, Rossi M, Capurso G, Scarpa A, Cascinu S, Tomassetti P, Falconi M, Delle Fave G. Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. Pancreas 2014 Mar;43(2):212-8. (IF:2.9)
61. Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-Saccà M, Piccolo S, De Maria R. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene. 2014 Feb 17. doi: 10.1038/onc.2014.5. (IF:7.35)
62. Lahner E, Esposito G, Pilozzi E, Galli G, Corleto VD, Di Giulio E, Annibale B. Gastric cancer in patients with type I gastric carcinoids. Gastric Cancer. 2014 Jun 3. [Epub ahead of print] (IF: 4.8)
63. Anania G, Gigante E, Piciucchi M, Pilozzi E, Pucci E, Pellicelli AM, Capotondi C, Rossi M, Baccini F, Antonelli G, Begini P, Delle Fave G, Marignani M. Liver biopsy: Analysis of results of two specialist teams. World J Gastrointest Pathophysiol. 2014 May 15;5(2):114-9.
64. Galli G, Esposito G, Lahner E, Pilozzi E, Corleto VD, Di Giulio E, Aloe Spiriti MA, Annibale B. Histological recovery and gluten-free diet adherence: a prospective 1-year follow-up study of adult patients with coeliac disease. Aliment Pharmacol Ther. 2014 40(6):639-47. (IF: 5.4)
65. La Torre M, Nigri G, Mazzuca F, Ferri M, Botticelli A, Lorenzon L, Pilozzi E, Ziparo V. Standard versus limited colon resection for high risk T1 colon cancer. A matched case-control study. J Gastrointestin Liver Dis 2014, 23(3):285-90. (IF: 1.9)
66. Lahner E, Galli G, Esposito G, Pilozzi E, Corleto VD, Annibale B. Updated features associated with type 1 gastric carcinoids patients: a single-center study. Scand J Gastroenterol. 2014, 13:1-9 (IF: 2.33)
67. Lorenzon L, Mazzetta F, Pilozzi E, Uggeri G, Torrisi MR, Ferri M, Ziparo V, French D. Human Papilloma Virus does not have a casual role in colorectal carcinoma. World Journal of Gastroenterology 2015, 21:342-350. (IF:2.47)
68. Pilozzi E, Maresca C, Duranti E, Giustiniani MC, Catalanotto C, Lucarelli M, Cogoni C, Ferri M, Ruco L, Zardo G. Left-sided early onset versus late onset colorectal carcinomas:histological, clinical and molecular differences. American Journal of Clinical Pathology 2015, 143:1-11 (IF:3.1).